Purchase Short-Term Access

Compared with warfarin, high-dose dabigatran might be cost-effective for preventing stroke in older patients with nonvalvular AF

Nasseer A. Masoodi, MD, FACP

Annals of Internal Medicine 2011;154:JC6-12. doi:10.7326/0003-4819-154-12-201106210-02012

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)